UNC researchers identify virus gene involved in tumor cell growth, spread

CHAPEL HILL -- In studying a virus that causes the skin cancer Kaposi's sarcoma, University of North Carolina at Chapel Hill scientists have identified a viral gene that switches on cellular genes involved in promoting tumor cell growth and metastasis throughout the body.

The K1 gene in Kaposi's sarcoma-associated herpesvirus (KSHV) initiates these processes by causing cells to secrete growth and invasive factors.

Since there is no cure for herpesviruses, the discovery of this gene's role in the growth and spread of the sarcoma raises the possibility that a treatment aimed at blocking K1's function may help to slow and contain the disease, the research team reported.

The new findings appeared in the April 14 issue of the journal Cancer Research.

"If you target the initiation process then you might prevent growth and metastasis from occurring," said Dr. Blossom Damania, assistant professor of microbiology and immunology at UNC's School of Medicine. She is the study's senior author and a member of the UNC Lineberger Comprehensive Cancer Center.

Previous research has found that K1, when inserted into normal cells, can make them cancerous. In addition, others have shown that mice bred to express this gene develop skin lesions.

The UNC research shows for the first time how K1 does this in different cell types, Damania said. Kaposi's sarcoma is an angiogenic tumor, meaning that the tumor can recruit blood vessels to the tumor site, and the sarcoma is also known to metastasize. Damania's research team investigated the action of K1 in blood vessel endothelial cells and skin epithelial cells.

"We observed that K1 up-regulates vascular endothelial growth factor, VEGF. This growth factor leads to greater recruitment of blood vessels to the site of the tumor, which supplies nutrients and allows the tumor to grow," she said.

The UNC research also showed that K1 increases expression of matrix metalloproteinase-9, an enzyme that breaks

Contact: Leslie Lang
University of North Carolina School of Medicine

Page: 1 2

Related biology news :

1. Belgian researchers explore revolutionary approach to angiogenesis
2. Award winning researchers reveal potential new role for Glivec
3. $7.5 Million grant to Yale researchers for role of viruses in cancer
4. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
5. Joslin researchers clarify mechanisms for beta-cell formation
6. Virginia Tech researchers to release findings on Smith River Project
7. Molecular motor myosin VI moves hand over hand, researchers say
8. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
9. Emory researchers map structure of anti-cancer molecule
10. Leukemia stem cells identified by Stanford researchers
11. EURYI Award given for the first time to 25 young European researchers

Post Your Comments:

(Date:4/22/2020)... WAYNE, Pa. (PRWEB) , ... April 20, 2020 , ... ... Sciences and Healthcare firms of all sizes, announces the hiring of Michael Wlodarczyk as ... Wlodarczyk has been tasked to support and grow the company’s already strong presence across ...
(Date:4/18/2020)... ... 16, 2020 , ... SIRION Biotech GmbH , a world leader in ... present a company update on its work expediting gene therapy research and advancing drug ... 22 and 23. Dieter Lingelbach, the Company’s Chief Operating Officer, will also provide an ...
(Date:4/15/2020)... ... 15, 2020 , ... NDA Partners Chairman Carl Peck, MD , announced ... Policy Advisor with the Center for Drug Evaluation and Research and former Branch Chief ... has joined the firm as an Expert Consultant. , Dr. Suleiman has expertise in ...
Breaking Biology News(10 mins):
(Date:5/5/2020)... Fla. (PRWEB) , ... May 05, 2020 , ... ... and solutions company, announced today the launch of its iGlucose® LTE ... new iGlucose solution utilizes LTE Cat-M1 technology, the industry’s newest and broadest cellular ...
(Date:4/22/2020)... Ohio (PRWEB) , ... April 21, 2020 , ... ... Biophen™ FXIII chromogenic method for determination of FXIII. , Aniara Diagnostica, a multi-national ... its commitment to meeting today’s highest standards for product quality and cost-efficient delivery. ...
(Date:4/1/2020)... Ky. (PRWEB) , ... March 30, 2020 , ... ... launch of its latest product, ArmourGuard® RTU, an EPA-approved spray-on antimicrobial solution. As ... only biosecurity solution that provides continual antimicrobial activity against microorganisms for up to ...
(Date:3/27/2020)... ... March 25, 2020 , ... ... opening of its veterinary histopathology laboratory located centrally in the midwest for ... ability to work with a highly motivated, independent, professional team that is ...
Breaking Biology Technology:
Cached News: